Why Lynas shares could crash 33%

Bell Potter believes this rare earths stock could lose a third of its value.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It is fair to say that Lynas Rare Earths Ltd (ASX: LYC) shares have been on fire over the past 12 months.

During this time, the rare earths producer's shares have risen an impressive 150%.

This has been driven by growing demand for rare earths and Chinese export restrictions.

A man slumps crankily over his morning coffee as it pours with rain outside.

Image source: Getty Images

Is it too late to buy Lynas shares?

The team at Bell Potter thinks it is too late to invest and is urging investors to sell their shares if they own them. Especially after Lynas' quarterly update fell short of expectations.

Commenting on the quarter, Bell Potter highlights that its production and revenue were short of expectations. Though, it does acknowledge that the company's realised price was higher than forecast, which bodes well for its margins. It said:

LYC produced 1,404t NdPr (BPe 2,100t VA Cons 1,700t) and 978t other rare earths. The December quarter was plagued by power outages in Kalgoorlie and planned maintenance in Kuantan. LYC's achieved basket price hit a record $86/kg (BPe $60/kg VA Cons $67/kg). Revenue was $202m (BPe $279m VA Cons $206m). Cash operating costs were $140m, up from $115m in 1QFY26, equating to cash costs of $59/kg TREO.

Payments for capital expenditure were $45m, down from $66m in 1QFY26. LYC finished 1QFY26 with $1,030m in cash, down from $1,060m in 1QFY26. Whilst the result disappointed on production, the power outages look to be resolved (for now). The higher than forecast basket price appears to have been driven by mix and product premiums. Whilst it is uncertain how long LYC can manage this, it does bode well for near-term margin protection.

Time to sell

According to the note, the broker has retained its sell rating on Lynas shares with an improved price target of $11.15.

Based on its current share price of $16.75, this implies potential downside of 33% for investors over the next 12 months.

Although the broker is a fan of the company, it just simply isn't a fan of its valuation. Commenting on its sell recommendation, Bell Potter said:

Our target price increases to $11.15/sh (previously $9.60/sh), and we maintain our Sell recommendation. Whilst we like the business, asset, and team, we believe there is significant optimism priced into the stock, with investors using it as a hedge on US-China relations. Earnings changes in this report include: FY26 -16%, FY27 nc [no change], FY28 nc.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Lynas Rare Earths Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Broker Notes

2 ASX 200 stocks drawing fresh buy ratings this week 

These shares have solid upside.

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Magellan and Ramsay Health Care shares

A leading expert forecasts growing headwinds for Magellan and Ramsay Health Care shares. But why?

Read more »

Pilot on the phone looking distraught.
Broker Notes

Sell alert! Why this expert is ditching Qantas shares for this ASX 200 defence stock

A leading expert is selling Qantas shares and buying this surging ASX 200 defence stock instead. But why?

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

Up 64%, 3 reasons this expert predicts Pro Medicus shares will keep on giving

A leading expert forecasts more outperformance from the surging Pro Medicus share price.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »

A scientist in a white coat and glasses puts her arms in the air in a sign of strength and success.
Broker Notes

Morgans tips a 600%+ return for this ASX biotech stock

Good clinical study progress has the broker bullish on this company.

Read more »

Wlorker on a laptop on top of solar panels.
Broker Notes

Up 8%, should I buy the rebound in Origin Energy shares today?

A leading analyst provides his forecast for Origin Energy’s rebounding shares.

Read more »

A woman stands in a field and raises her arms to welcome a golden sunset.
Gold

4 ASX 200 gold shares to buy: Experts

Experts explain their buy ratings following these miners' June quarter reports.

Read more »